16 Spam-Free Article(s) Found
Article Searches
Teva prevails in migraine patent dispute; shares up 9% https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-shares-up-9?source=feed_sector_healthcare Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
3 Ridiculously Cheap Buffett Stocks to Buy Now https://www.fool.com/investing/2020/03/31/3-ridiculously-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001 Mar 31, 2020 - It's been a while since the Oracle of Omaha had bargains like this in his portfolio.
FDA Authorizes Use of Old Malaria Drugs to Treat COVID-19 https://www.fool.com/investing/2020/03/30/fda-authorizes-use-of-old-malaria-drugs-to-treat-c.aspx?source=iedfolrf0000001 Mar 30, 2020 - Despite scant clinical evidence that they work, the FDA issued its first emergency use authorization for therapeutic products to treat the novel coronavirus.
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181 Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know http://www.zacks.com/stock/news/837115/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-837115 Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
Teva Pharmaceuticals Near 20-Year Lows https://seekingalpha.com/article/4332825-teva-pharmaceuticals-near-20-year-lows?source=feed_tag_israel Mar 18, 2020 -

Pages: 12

<Page 2